Frankly guys, this study is not terribly interesting.

A) It's open label.

B) There's no placebo cohort but rather an age and disease matched control group.

C) About 45 people dropped out. Maybe because they were doing well. Or poorly. Or became pregnant. Or?

On the positive side there appeared to be a 40%-50% reduction in relapse rate in the treated group vs. controls.

I think "up to a 45% reduction" means that that was the best result of any of the four therapies, but the other three must have been close, since the differences between the four were not statistically significant.

But again, because of the methodological problems, I think we shouldn't make too much of this study.

Mark